MARY TAGLIAFERRI

Insider Reports History

Location
San Francisco, CA
Signature
/s/ John LaRocca, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by MARY TAGLIAFERRI:

Company Role Class Num Shares Value Price $ Report Date Ownership
ENZO BIOCHEM INC Director Common Stock 312,383 $481,070 $1.54 31 Jan 2024 Direct
Y-mAbs Therapeutics, Inc. Director Common Stock 8,155 $97,860 $12.00 11 Jun 2024 Direct
Y-mAbs Therapeutics, Inc. Director Employee Stock Option (right to buy) 14,545 11 Jun 2024 Direct
RayzeBio, Inc. Director Employee Stock Option (right to buy) 0 26 Feb 2024 Direct

Insider Reports Filed by MARY TAGLIAFERRI

Symbol Company Period Transactions Value $ Form Type Role Filing Time
YMAB Y-mAbs Therapeutics, Inc. 11 Jun 2024 2 $0 4 Director 13 Jun 2024, 21:02
YMAB Y-mAbs Therapeutics, Inc. 12 Mar 2024 2 $0 4 Director 14 Mar 2024, 17:01
YMAB Y-mAbs Therapeutics, Inc. 29 Feb 2024 0 $0 3 Director 08 Mar 2024, 06:17
/report/000141588924005538-tagliaferri-mary-2024-02-26 RayzeBio, Inc. 26 Feb 2024 2 $0 4 Director 27 Feb 2024, 17:04
ENZB ENZO BIOCHEM INC 31 Jan 2024 1 $0 4 Director 02 Feb 2024, 21:01
/report/000120919123049508-tagliaferri-mary-2023-09-14 RayzeBio, Inc. 14 Sep 2023 0 $0 3 Director 14 Sep 2023, 19:31
ENZB ENZO BIOCHEM INC 09 Feb 2023 1 $0 4 Director 13 Feb 2023, 20:39
ENZB ENZO BIOCHEM INC 12 Jul 2022 1 $0 4 Director 14 Jul 2022, 21:32
ENZB ENZO BIOCHEM INC 27 Apr 2022 1 $0 4 Director 29 Apr 2022, 16:44